MARKET

ABSI

ABSI

Absci Corp
NASDAQ
2.740
+0.170
+6.61%
After Hours: 2.730 -0.01 -0.37% 19:59 07/16 EDT
OPEN
2.630
PREV CLOSE
2.570
HIGH
2.750
LOW
2.580
VOLUME
4.54M
TURNOVER
--
52 WEEK HIGH
6.33
52 WEEK LOW
2.010
MARKET CAP
349.51M
P/E (TTM)
-2.9647
1D
5D
1M
3M
1Y
5Y
1D
Largest borrow rate increases among liquid names
TipRanks · 2d ago
Weekly Report: what happened at ABSI last week (0707-0711)?
Weekly Report · 2d ago
Largest borrow rate increases among liquid names
TipRanks · 6d ago
Absci Corporation Files Initial Statement of Beneficial Ownership for Director Mary T. Szela
Reuters · 07/09 20:44
AbSci Appoints Mary Szela to Board of Directors
TipRanks · 07/08 21:58
IRHYTHM TECHNOLOGIES ANNOUNCES BOARD MEMBER RETIREMENTS AND NEW DIRECTOR APPOINTMENTS
Reuters · 07/07 12:30
Absci appoints Mary Szela to board of directors
TipRanks · 07/07 12:05
Absci Corporation Appoints Biopharma Veteran Mary Szela to Board of Directors, Boosting AI-Driven Drug Discovery Leadership
Reuters · 07/07 12:00
More
About ABSI
Absci Corporation is a clinical-stage biopharmaceutical company advancing therapeutics with generative design. Its Integrated Drug Creation platform combines artificial intelligence (AI) models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. Its approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Alongside collaborations with pharmaceutical, biotech, tech, and academic companies, the Company is advancing its own pipeline of AI- designed therapeutics. These include ABS-101, an antibody to treat inflammatory bowel disease (IBD), as well as other indications, and ABS-201, for hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern baldness. It has four wholly owned, internally developed programs focusing on cytokine biology. Its other pipeline programs include ABS-301 and ABS-501.

Webull offers Absci Corp stock information, including NASDAQ: ABSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABSI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABSI stock methods without spending real money on the virtual paper trading platform.